Wells Fargo’s Erasca ERAS Stock Holding History

Wells Fargo’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Buy	+126,400	New	+$1.81M	﹤0.01%	3471

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Wells Fargo's ERAS Position: Q2 2026 in Review

Wells Fargo increased its Erasca (ERAS) stake by 171% in Q2 2026, buying an estimated $2.62M and bringing the position to 290,523 shares worth $5.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

Wells Fargo first reported a position in ERAS in Q3 2021 and has held it in 20 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

Wells Fargo held 290,523 shares of Erasca worth $5.32M as of Q2 2026.
Wells Fargo bought 183,347 Erasca shares in Q2 2026, an estimated $2.62M.
Erasca made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2783 holding.
Wells Fargo first reported a position in Erasca in Q3 2021 and has held it in 20 quarters since.
257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.